학술논문
Efficacy and safety of empagliflozin twice daily versus once daily in patients with type 2 diabetes inadequately controlled on metformin: A 16-week, randomized, placebo-controlled trial
Document Type
Article
Author
Source
In: Diabetes, Obesity and Metabolism . (Diabetes, Obesity and Metabolism, 1 July 2015, 17(7):699-702)
Subject
Language
English
ISSN
14631326
14628902
14628902